Quest Diagnostics Incorporated
Sam Samad (Executive Vice President & CFO) reports DGX insider transactions
AI-generated summary
Sam Samad, Executive Vice President & CFO of Quest Diagnostics Incorporated, received 90 shares as a grant on October 21, 2026, with a total value of $21,234.51 at an average price of $235.94. Following this transaction, the insider directly holds 33,568 shares.
Key facts
- Insider
- Sam Samad · Executive Vice President & CFO
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | A · grantFootnotes F1 | +90 | $235.94 | $21,234.51 | 33,568 | Direct |
Footnotes
- F1 Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
More DGX filings
- 4
Filed Oct 28, 2026
- 144
Filed Oct 26, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.